Scope

• Examines the provision of online DM tools by various stakeholders, including secondary care organizations, health plans and pharmaceutical companies
• Looks at the provision of tools to support differing levels of patient and clinical disease management
• Considers the challenges facing the online disease management market such as how to identify and target patients and how best to demonstrate ROI
• Explores factors driving the adoption of online DM tools including the growing use of mobile technology and the use of DM tools in clinical trials

Report Highlights

The software used in online DM programs no longer necessitates the use of PC-based technology; programs are being developed for PDAs, televisions, cellular phones, network devices and potentially even gaming stations.

The capture and management of clinical trial data are a sizeable component of the clinical trial process in terms of time and cost. Complementing electronic patient diaries with DM programs will help reduce costs and improve process efficiencies.

Online DM programs generally require a substantial amount of self-management from patients; without their buy-in, the effectiveness of these programs is severely limited for all the stakeholders. However, a challenge lies in improving patient compliance in terms of managing their condition.

Benefits

• Identify the roles of relationships between the various stakeholders in the online DM market
• Understand the various demands on online DM tools in meeting the requirements of patients and physicians
• Recognize the future drivers in the online DM market and how they will impact the decision-making process

Sent in Adobe Acrobat PDF format

37 pages